UnitedHealth Group Incorporated $UNH Shares Newly Purchased by Mirae Asset Global Investments Co. Ltd.

Key Points

• Mirae Asset Global Investments purchased 726,156 UnitedHealth shares worth approximately $266.6 million, giving it a 0.08% stake. Institutional investors collectively own 87.86% of the company.
• UnitedHealth reported quarterly EPS of $4.69, beating estimates by $0.55, while revenue reached $112.7 billion. The company also pays a quarterly dividend of $2.32 per share, equivalent to a 2.3% yield.
• Analysts hold a “Moderate Buy” consensus with an average price target of $463.93, though high medical costs, commercial insurance and Medicaid performance, and near-term earnings pressure remain key risks.

Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 726,156 shares of the healthcare conglomerate's stock, valued at approximately $266,557,000. Mirae Asset Global Investments Co. Ltd. owned about 0.08% of UnitedHealth Group as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in UNH. City State Bank raised its position in UnitedHealth Group by 5.6% in the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate's stock worth $173,000 after acquiring an additional 25 shares during the period. Murphy Pohlad Asset Management LLC grew its position in shares of UnitedHealth Group by 0.5% during the 3rd quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate's stock valued at $1,947,000 after acquiring an additional 25 shares during the period. LFG Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 3.3% in the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate's stock worth $355,000 after purchasing an additional 27 shares in the last quarter. Synergy Financial Group LTD raised its holdings in UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate's stock worth $369,000 after purchasing an additional 27 shares during the period. Finally, Ares Financial Consulting LLC lifted its position in UnitedHealth Group by 7.2% during the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate's stock valued at $174,000 after purchasing an additional 28 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.19% of the company's stock.

UnitedHealth Group Stock Down 1.0%

NYSE UNH opened at $406.67 on Friday. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock has a market cap of $365.02 billion, a PE ratio of 23.23, a P/E/G ratio of 1.47 and a beta of 0.60. The stock's 50 day moving average is $390.20 and its 200 day moving average is $362.40.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. The business had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company's revenue was down .4% on a year-over-year basis. During the same period last year, the firm posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group's dividend payout ratio (DPR) is presently 53.00%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Improving margins and higher price target: Morgan Stanley said UnitedHealth’s margins are recovering, with Medicare operations returning to a more normal range, and raised its price target. However, commercial insurance, Medicaid and increased AI-related spending remain important execution tests. UnitedHealth is bouncing back, but a major risk remains
• Positive Sentiment: Recent earnings beat and raised guidance: UnitedHealth’s latest quarterly results exceeded expectations for both earnings and revenue, and the company raised its outlook. The earnings recovery supports the case that operating performance is stabilizing after earlier pressure. Why Did UnitedHealth Raise Guidance After Its Quarterly Beat?
• Positive Sentiment: Dividend appeal: UnitedHealth is highlighted as a major healthcare dividend payer, potentially supporting demand from income-focused investors. The article also cautions that dividend safety should be assessed alongside payout sustainability and business risks. $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
• Neutral Sentiment: Analyst estimates are mixed: Zacks Research maintained a “Hold” rating and projects roughly $20.54 in FY2026 EPS, close to the broader consensus near $20.62. It raised several longer-term quarterly estimates but lowered others, including Q1 2027, Q1 2028 and Q2 2028.
• Negative Sentiment: Near-term earnings pressure: Zacks Research issued a negative estimate for fourth-quarter earnings, adding to concerns that high medical utilization and costs could limit profitability despite the Medicare recovery. Zacks Research Has Negative Estimate for UNH Q4 Earnings

Analyst Ratings Changes

Several research firms have issued reports on UNH. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $516.00 to $524.00 and gave the company an "overweight" rating in a report on Friday, October 16th. Oppenheimer lifted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the company an "outperform" rating in a research report on Friday, July 17th. Erste Group Bank downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Thursday, August 27th. Piper Sandler raised their target price on shares of UnitedHealth Group from $502.00 to $504.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 14th. Finally, Weiss Ratings raised shares of UnitedHealth Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, October 8th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $463.93.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.